Showing results (2031-2040 of 5,146) with videos related to

Sort By:
Pageof 515
Multiple Sclerosis and Related Disorders|June 20, 2020
The increasing economic burden of multiple sclerosis by disability severity in Australia in 2017: Results from updated and detailed data on types of costsHasnat Ahmad, Julie A Campbell, Ingrid van der Mei, et al.
Multiple Sclerosis and Related Disorders|June 20, 2020
COVID-19 prevention and multiple sclerosis management: The SAFE pathway for the post-peakAntonio Buonomo, Vincenzo Brescia Morra, Emanuela Zappulo, et al.
Multiple Sclerosis and Related Disorders|August 8, 2022
Pattern of thalamic nuclei atrophy in early relapse-onset multiple sclerosisSarah Levy, Joshua Sandry, Erin S Beck, et al.
Multiple Sclerosis and Related Disorders|August 1, 2022
The heterogeneity of tissue destruction between iron rim lesions and non-iron rim lesions in multiple sclerosis: A diffusion MRI studyHai Hu, Long Ye, Shuang Ding, et al.
Multiple Sclerosis and Related Disorders|February 22, 2023
Effect of deep gray matter atrophy on information processing speed in early relapsing-remitting multiple sclerosisSaba Naghavi, Fereshteh Ashtari, Iman Adibi, et al.
Multiple Sclerosis and Related Disorders|March 18, 2023
In-depth characterization of long-term humoral and cellular immune responses to COVID-19m-RNA vaccination in multiple sclerosis patients treated with teriflunomide or alemtuzumabAnat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, et al.
Multiple Sclerosis and Related Disorders|February 22, 2023
Telerehabilitation versus virtual reality supported task-oriented circuit therapy on upper limbs and trunk functions in patients with multiple sclerosis: A randomized controlled studyMert Doğan, Ender Ayvat, Muhammed Kılınç
Multiple Sclerosis and Related Disorders|March 24, 2023
Characteristics and consequences of falls among people with multiple sclerosis who use wheelchairs or scooters: Differences between injurious and non-injurious fallsTobia Zanotto, Jacob J Sosnoff, Deborah Backus, et al.
Multiple Sclerosis and Related Disorders|February 26, 2023
Predictors of hospitalization due to infection in rituximab-treated MS patientsJakob Rishovd Karlowicz, Mattias Klakegg, Jan Harald Aarseth, et al.
Multiple Sclerosis and Related Disorders|March 2, 2023
Effectiveness and safety of switching from fingolimod and natalizumab to rituximab in patients with relapsing remitting multiple sclerosisAli Ussama Fakih, Mohammad Ali Sahraian, Sepideh Paybast, et al.
Pageof 515